Agonists and Antagonists of Protease-Activated Receptor 2 Discovered within a DNA-Encoded Chemical Library Using Mutational Stabilization of the Target

Author:

Brown Dean G.1,Brown Giles A.2,Centrella Paolo3,Certel Kaan34,Cooke Robert M.2,Cuozzo John W.3,Dekker Niek5,Dumelin Christoph E.36,Ferguson Andrew17,Fiez-Vandal Cédric2,Geschwindner Stefan5ORCID,Guié Marie-Aude3,Habeshian Sevan38,Keefe Anthony D.3,Schlenker Oliver2,Sigel Eric A.3,Snijder Arjan5,Soutter Holly T.3,Sundström Linda5,Troast Dawn M.39,Wiggin Giselle2,Zhang Jing110,Zhang Ying3,Clark Matthew A.3

Affiliation:

1. Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D, Waltham, MA, USA

2. Heptares Therapeutics Ltd., Welwyn Garden City, Hertfordshire, UK

3. X-Chem Pharmaceuticals, Waltham, MA, USA

4. Novartis Institute for BioMedical Research, Cambridge, MA, USA

5. Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D, Mölndal, Sweden

6. Novartis Institute for BioMedical Research, Basel, Switzerland

7. X-Chem, Inc., Waltham, MA, USA

8. École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland

9. Morphic Therapeutic, Waltham, MA

10. Entasis Therapeutics, Waltham, MA

Abstract

The discovery of ligands via affinity-mediated selection of DNA-encoded chemical libraries is driven by the quality and concentration of the protein target. G-protein-coupled receptors (GPCRs) and other membrane-bound targets can be difficult to isolate in their functional state and at high concentrations, and therefore have been challenging for affinity-mediated selection. Here, we report a successful selection campaign against protease-activated receptor 2 (PAR2). Using a thermo-stabilized mutant of PAR2, we conducted affinity selection using our >100-billion-compound DNA-encoded library. We observed a number of putative ligands enriched upon selection, and subsequent cellular profiling revealed these ligands to comprise both agonists and antagonists. The agonist series shared structural similarity with known agonists. The antagonists were shown to bind in a novel allosteric binding site on the PAR2 protein. This report serves to demonstrate that cell-free affinity selection against GPCRs can be achieved with mutant stabilized protein targets.

Publisher

Elsevier BV

Subject

Molecular Medicine,Biochemistry,Analytical Chemistry,Biotechnology

Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3